Neuphoria Therapeutics (NEUP) Leases (2024 - 2025)
Neuphoria Therapeutics (NEUP) has disclosed Leases for 2 consecutive years, with $75219.0 as the latest value for Q3 2025.
- On a quarterly basis, Leases fell 61.9% to $75219.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $75219.0, a 61.9% decrease, with the full-year FY2025 number at $102612.0, changed N/A from a year prior.
- Leases was $75219.0 for Q3 2025 at Neuphoria Therapeutics, down from $102612.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $197447.0 in Q3 2024 to a low of $75219.0 in Q3 2025.